Skip to main content

Advertisement

Log in

Reverse Hexagonal Phase Nanodispersion of Monoolein and Oleic Acid for Topical Delivery of Peptides: in Vitro and in Vivo Skin Penetration of Cyclosporin A

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Purpose

To obtain and characterize reverse hexagonal phase nanodispersions of monoolein and oleic acid, and to evaluate the ability of such system to improve the skin penetration of a model peptide (cyclosporin A, CysA) without causing skin irritation.

Methods

The nanodispersion was prepared by mixing monoolein, oleic acid, poloxamer, and water. CysA was added to the lipid mixture to obtain a final concentration of 0.6% (w/w). The nanodispersion was characterized; the skin penetration of CysA was assessed in vitro (using porcine ear skin mounted in a Franz diffusion cell) and in vivo (using hairless mice).

Results

The obtainment of the hexagonal phase nanodispersion was demonstrated by polarized light microscopy, cryo-TEM and small angle X-ray diffraction. Particle diameter was 181.77 ± 1.08 nm. At 0.6%, CysA did not change the liquid crystalline structure of the particles. The nanodispersion promoted the skin penetration of CysA both in vitro and in vivo. In vitro, the maximal concentrations (after 12 h) of CysA obtained in the stratum corneum (SC) and in the epidermis without stratum corneum (E) + dermis (D) were ∼2 fold higher when CysA was incorporated in the nanodispersion than when it was incorporated in the control formulation (olive oil). In vivo, 1.5- and 2.8-times higher concentrations were achieved in the SC and [E+D], respectively, when the nanodispersion was employed. No histopathological alterations were observed in the skin of animals treated with the nanodispersion.

Conclusion

These results demonstrate that the hexagonal phase nanodispersion is effective in improving the topical delivery of peptides without causing skin irritation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. M. G. Carr J. Corish O. I. Corrigan (1997) ArticleTitleDrug delivery from a liquid crystalline base across Visking and human stratum corneum Int. J. Pharm. 157 35–42 Occurrence Handle1:CAS:528:DyaK2sXmsVKks70%3D Occurrence Handle10.1016/S0378-5173(97)00209-3

    Article  CAS  Google Scholar 

  2. J. Lee I. W. Kellaway (2000) ArticleTitleBuccal permeation of [d-Ala, d-Leu] enkephalin from liquid crystalline phases of glyceryl monooleate Int. J. Pharm. 195 35–38 Occurrence Handle10675680 Occurrence Handle1:CAS:528:DC%2BD3cXhtV2hs7w%3D Occurrence Handle10.1016/S0378-5173(99)00357-9

    Article  PubMed  CAS  Google Scholar 

  3. J. Lee I. W. Kellaway (2000) ArticleTitleCombined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [d-Ala2, d-Leu5] enkephalin from a cubic phase of glyceryl monooleate Int. J. Pharm. 204 137–144 Occurrence Handle11011997 Occurrence Handle1:CAS:528:DC%2BD3cXmvVyktbY%3D Occurrence Handle10.1016/S0378-5173(00)00490-7

    Article  PubMed  CAS  Google Scholar 

  4. J. C. Shah Y. Sadhale D.M. Chilukuri (2001) ArticleTitleCubic phase as drug delivery systems Adv. Drug Deliv. Rev. 47 229–250 Occurrence Handle11311994 Occurrence Handle1:CAS:528:DC%2BD3MXislGls7c%3D Occurrence Handle10.1016/S0169-409X(01)00108-9

    Article  PubMed  CAS  Google Scholar 

  5. J. Borné T. Nylander A. Khan (2001) ArticleTitlePhase behavior and aggregate formation for the aqueous monoolein system mixed with sodium oleate and oleic acid Langmuir 17 7742–7751 Occurrence Handle10.1021/la010650w Occurrence Handle1:CAS:528:DC%2BD3MXotVCisLg%3D

    Article  CAS  Google Scholar 

  6. M. G. Lara M. V. L. B. Bentley J. H. Collet (2005) ArticleTitle In vitro drug release mechanism and drug loading studies of cubic phase gels Int. J. Pharm. 293 241–250 Occurrence Handle15778062 Occurrence Handle1:CAS:528:DC%2BD2MXitlSgtbs%3D Occurrence Handle10.1016/j.ijpharm.2005.01.008

    Article  PubMed  CAS  Google Scholar 

  7. A. Ganem-Quintanar D. Quintanar-Guerrero P. Buri (2000) ArticleTitleMonoolein: a review of the pharmaceutical applications Drug Dev. Ind. Pharm. 26 809–820 Occurrence Handle10900537 Occurrence Handle1:CAS:528:DC%2BD3cXks12ju7g%3D Occurrence Handle10.1081/DDC-100101304

    Article  PubMed  CAS  Google Scholar 

  8. L. S. Helledi L. Schubert (2001) ArticleTitleRelease kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system Drug Dev. Ind. Pharm. 27 1073–1081 Occurrence Handle11794810 Occurrence Handle1:CAS:528:DC%2BD38Xjt1GhtA%3D%3D Occurrence Handle10.1081/DDC-100108370

    Article  PubMed  CAS  Google Scholar 

  9. N. Merclin J. Bender E. Sparr R. H. Guy H. Ehrsson S. Engström (2004) ArticleTitleTransdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester J. Control. Release 100 191–198 Occurrence Handle15544867 Occurrence Handle1:CAS:528:DC%2BD2cXps1Oru7o%3D Occurrence Handle10.1016/j.jconrel.2004.08.025

    Article  PubMed  CAS  Google Scholar 

  10. A. C. Williams B. W. Barry (2004) ArticleTitlePenetration enhancer Adv. Drug Deliv. Rev. 56 603–618 Occurrence Handle15019749 Occurrence Handle1:CAS:528:DC%2BD2cXhvFWqsbo%3D Occurrence Handle10.1016/j.addr.2003.10.025

    Article  PubMed  CAS  Google Scholar 

  11. J. Gustafsson H. Ljusberg-Wahren M. Almgren K. Larsson (1996) ArticleTitleCubic-lipid–water phase dispersed into submicron particles Langmuir 12 4611–4613 Occurrence Handle1:CAS:528:DyaK28XlsFWisLs%3D Occurrence Handle10.1021/la960318y

    Article  CAS  Google Scholar 

  12. J. Gustafsson H. Ljusberg-Wahren M. Almgren K. Larsson (1997) ArticleTitleSubmicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer Langmuir 13 6964–6971 Occurrence Handle1:CAS:528:DyaK1cXhs1CgtQ%3D%3D Occurrence Handle10.1021/la970566+

    Article  CAS  Google Scholar 

  13. M. Nakano T. Teshigawara A. Sugita W. Leesajakul A. Taniguchi T. Kamo H. Matsuoka T. Handa (2002) ArticleTitleDispersions of liquid crystalline phases of the monoolein/oleic acid/pluronic F127 system Langmuir 18 9283–9288 Occurrence Handle1:CAS:528:DC%2BD38XotFSqurs%3D Occurrence Handle10.1021/la026297r

    Article  CAS  Google Scholar 

  14. K. Larsson (2000) ArticleTitleAqueous dispersions of cubic lipid–water phases Curr. Opin. Colloid Interface Sci. 5 64–69 Occurrence Handle1:CAS:528:DC%2BD3cXntVarsL8%3D Occurrence Handle10.1016/S1359-0294(00)00040-6

    Article  CAS  Google Scholar 

  15. B. Siekmann H. Bunjes M. H. J. Koch K. Westesen (2002) ArticleTitlePreparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride–water phases Int. J. Pharm. 244 33–43 Occurrence Handle12204563 Occurrence Handle1:CAS:528:DC%2BD38XmsVaiurk%3D Occurrence Handle10.1016/S0378-5173(02)00298-3

    Article  PubMed  CAS  Google Scholar 

  16. E. Esposito N. Eblovi S. Rasi M. Drechsler G. Gregorio ParticleDi E. Menegatti R. Cortesi (2003) ArticleTitleLipid-based supramolecular systems for topical application: a preformulatory study AAPS PharmSci. 5 1–15 Occurrence Handle10.1208/ps050430

    Article  Google Scholar 

  17. B. J. Boyd (2003) ArticleTitleCharacterisation of drug release from cubosomes using the pressure ultrafiltration method Int. J. Pharm. 260 239–247 Occurrence Handle12842343 Occurrence Handle1:CAS:528:DC%2BD3sXkvFektL8%3D Occurrence Handle10.1016/S0378-5173(03)00262-X

    Article  PubMed  CAS  Google Scholar 

  18. E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, and C. Puglia. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm. Res. 22:2163–2173 (2005).

    Google Scholar 

  19. J. I. Duncan S. N. Payne A. J. Winfield A. D. Ormerod A. W. Thomson (1990) ArticleTitleEnhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity Br. J. Dermatol. 123 631–640 Occurrence Handle2147390 Occurrence Handle1:CAS:528:DyaK3MXhslWisL4%3D

    PubMed  CAS  Google Scholar 

  20. D. D. Verma A. Fahr (2004) ArticleTitleSynergistic penetration effect of ethanol and phospholipids on the topical delivery of cyclosporin A J. Control. Rel. 97 55–66 Occurrence Handle1:CAS:528:DC%2BD2cXjvFOntrc%3D Occurrence Handle10.1016/j.jconrel.2004.02.028

    Article  CAS  Google Scholar 

  21. L. B. Lopes J. H. Collett M. V. L. B. Bentley (2005) ArticleTitleTopical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer Eur. J. Pharm. Biopharm. 60 25–30 Occurrence Handle15848052 Occurrence Handle1:CAS:528:DC%2BD2MXjsVehsbo%3D Occurrence Handle10.1016/j.ejpb.2004.12.003

    Article  PubMed  CAS  Google Scholar 

  22. G. Kellermann F. Vicentin E. Tamura M. Rocha H. Tolentino A. Barbosa A. Craievich I. Torriani (1997) ArticleTitleThe small-angle X-ray scattering beamline of the Brazilian Synchrotron Light Laboratory J. Appl. Crystallogr. 30 880–883 Occurrence Handle1:CAS:528:DyaK1cXotVOjtA%3D%3D Occurrence Handle10.1107/S0021889897001829

    Article  CAS  Google Scholar 

  23. A. F. Craievich (2002) ArticleTitleSynchrotron SAXS studies of nanostructured materials and colloidal solutions. A review Mater. Res. 5 1–11 Occurrence Handle1:CAS:528:DC%2BD38Xis1altLg%3D

    CAS  Google Scholar 

  24. J. R. Bellare H. T. Davis L. E. Scrie Y. Talmon (1988) ArticleTitleControlled environment vitrification system: an improved sample preparation technique J. Electron Microsc. Tech. 10 87–111 Occurrence Handle3193246 Occurrence Handle1:STN:280:BiaD2MrjvFE%3D Occurrence Handle10.1002/jemt.1060100111

    Article  PubMed  CAS  Google Scholar 

  25. L. B. Lopes C. M. Brophy E. Furnish C. R. Flynn O. Sparks P. Komalavilas L. Joshi A. Panitch M. V. Bentley (2005) ArticleTitleComparative study of the skin penetration of protein transduction domains and a conjugated peptide Pharm. Res. 22 750–757 Occurrence Handle15906170 Occurrence Handle1:CAS:528:DC%2BD2MXkt1Omsrk%3D Occurrence Handle10.1007/s11095-005-2591-x

    Article  PubMed  CAS  Google Scholar 

  26. M. Foldvari M. E. Baca-Estrada Z. He J. Hu S. Attah-Poku M. King (1999) ArticleTitleDermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon-α Biotechnol. Appl. Biochem. 30 129–137 Occurrence Handle10512792 Occurrence Handle1:CAS:528:DyaK1MXmslaqsb8%3D

    PubMed  CAS  Google Scholar 

  27. E. Touitou N. Dayan L. Bergelson B. Godin M. Eliaz (2000) ArticleTitleEthosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties J. Control. Rel. 65 403–418 Occurrence Handle1:CAS:528:DC%2BD3cXhtl2qsbo%3D Occurrence Handle10.1016/S0168-3659(99)00222-9

    Article  CAS  Google Scholar 

  28. G. R. Pereira J. H. Collett S. B. Garcia J. A. Thomazini M. V. L. B. Bentley (2002) ArticleTitleGlycerol monooleate/solvents systems for progesterone transdermal delivery: in vitro permeation and microscopic studies Braz. J. Pharm. Sci. 38 55–62 Occurrence Handle1:CAS:528:DC%2BD38XlsFShurg%3D

    CAS  Google Scholar 

  29. J. Guo Q. Ping G. Sun C. Jiao (2000) ArticleTitleLecithin vesicular carriers for transdermal delivery of cyclosporin A Int. J. Pharm. 194 201–207 Occurrence Handle10692644 Occurrence Handle1:CAS:528:DC%2BD3cXht1eqtrc%3D Occurrence Handle10.1016/S0378-5173(99)00361-0

    Article  PubMed  CAS  Google Scholar 

  30. A. Sintov A. Ze’evi R. Uzan A. Nyska (1999) ArticleTitleInfluence of pharmaceutical gel vehicles containing oleic acid/sodium oleate combinations on hairless mouse skin, a histological evaluation Eur. J. Pharm. Biopharm. 47 299–303 Occurrence Handle10382116 Occurrence Handle1:STN:280:DyaK1MzhtFWhtw%3D%3D Occurrence Handle10.1016/S0939-6411(99)00018-1

    Article  PubMed  CAS  Google Scholar 

  31. R. Alvarez-Román A. Naik Y. N. Kalia H. Fessi R. H. Guy (2004) ArticleTitleVisualization of skin penetration using confocal laser scanning microscopy Eur. J. Pharm. Biopharm. 58 301–316 Occurrence Handle15296957 Occurrence Handle10.1016/j.ejpb.2004.03.027 Occurrence Handle1:CAS:528:DC%2BD2cXmsVGns7o%3D

    Article  PubMed  CAS  Google Scholar 

  32. H. Chung J. Kim J. Y. Um I. C. Kwon S. Y. Jeong (2002) ArticleTitleSelf-assembled “nanocubicle” as a carrier for peroral insulin delivery Diabetologia 45 448–451 Occurrence Handle11914752 Occurrence Handle1:CAS:528:DC%2BD38XitVeisro%3D Occurrence Handle10.1007/s00125-001-0751-z

    Article  PubMed  CAS  Google Scholar 

  33. J. Y. Um H. Chung K. S. Kim I. C. Kwon S. Y. Jeong (2003) ArticleTitle In vitro cellular interaction and absorption of dispersed cubic particles Int. J. Pharm. 253 71–80 Occurrence Handle12593938 Occurrence Handle1:CAS:528:DC%2BD3sXht1Wmsbw%3D Occurrence Handle10.1016/S0378-5173(02)00673-7

    Article  PubMed  CAS  Google Scholar 

  34. F. Caboi G. S. Amico P. Pitzalis M. Monduzzi T. Nylander K. Larsson (2001) ArticleTitleAddition of hydrophilic and lipophilic compound of biological relevance to the monoolein/water system. I—Phase behavior Chem. Phys. Lipids 109 47–62 Occurrence Handle11163344 Occurrence Handle1:CAS:528:DC%2BD3MXitlyrtQ%3D%3D Occurrence Handle10.1016/S0009-3084(00)00200-0

    Article  PubMed  CAS  Google Scholar 

  35. K. Moser K. Kriwet A. Naik Y. N. Kalia R. H. Guy (2001) ArticleTitlePassive skin penetration enhancement and its quantification in vitro Eur. J. Pharm. Bipharm. 82 103–112

    Google Scholar 

  36. K. Moser K. Kriwet A. Naik Y. N. Kalia R. H. Guy (2001) ArticleTitlePassive skin penetration enhancement and its quantification in vitro Eur. J. Pharm. Bipharm. 82 103–112

    Google Scholar 

  37. W. G. Reinfarah G. S. Hawkins M. S. Kurtz (1991) ArticleTitlePercutaneous penetration and skin retention of topically applied compounds: an in vitroin vivo study J. Pharm. Sci. 80 526–531

    Google Scholar 

  38. S. M. Dowton C. Hu C. Ramachandram D. H. F. Wallach N. Weiner (1993) ArticleTitleInfluence of liposomal composition on topical delivery of encapsulated cyclosporin A. I. An in vitro study using hairless mouse skin STP Pharma Sci. 3 404–407 Occurrence Handle1:CAS:528:DyaK2cXhslehurg%3D

    CAS  Google Scholar 

  39. K. S. Black D. K. Nguyen C. M. Proctor M. P. Patel C. W. Hewitt (1990) ArticleTitleSite-specific suppression of cell-mediated immunity by cyclosporine J. Invest. Dermatol. 94 644–648 Occurrence Handle2324520 Occurrence Handle1:CAS:528:DyaK3cXktFOltro%3D Occurrence Handle10.1111/1523-1747.ep12876218

    Article  PubMed  CAS  Google Scholar 

  40. T. Ogiso M. Ywaki T. Paku (1995) ArticleTitleEffect of various enhancers on transdermal penetration of indomethacin and urea and relationship between penetration parameters and enhancement factors J. Pharm. Sci. 84 482–488 Occurrence Handle7629741 Occurrence Handle1:CAS:528:DyaK2MXksVKls7o%3D

    PubMed  CAS  Google Scholar 

  41. G. Cevc H. Richardsen (1999) ArticleTitleLipid vesicles and membrane fusion Adv. Drug Deliv. Rev. 38 207–232 Occurrence Handle10837758 Occurrence Handle1:CAS:528:DyaK1MXlt1Sis7Y%3D Occurrence Handle10.1016/S0169-409X(99)00030-7

    Article  PubMed  CAS  Google Scholar 

  42. C. Cevc G. Blume A. Schatzelein D. Gebauer A. Paul (1996) ArticleTitleThe skin: a pathway for systemic treatment with patches and lipid-based agent carriers Adv. Drug Deliv. Rev. 18 349–378 Occurrence Handle1:CAS:528:DyaK28XhtlWhs7c%3D Occurrence Handle10.1016/0169-409X(95)00091-K

    Article  CAS  Google Scholar 

  43. C. Cevc (2004) ArticleTitleLipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 675–711 Occurrence Handle15019752 Occurrence Handle1:CAS:528:DC%2BD2cXhvFWqsbk%3D Occurrence Handle10.1016/j.addr.2003.10.028

    Article  PubMed  CAS  Google Scholar 

  44. T. F. Zioncheck S. A. Chen L. Richardson M. Mora-Worms C. Lucas D. Lewis J. D. Green J. Mordenti (1994) ArticleTitlePharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats Pharm. Res. 11 213–220 Occurrence Handle8165178 Occurrence Handle1:CAS:528:DyaK2cXhvVeqt7g%3D Occurrence Handle10.1023/A:1018995005775

    Article  PubMed  CAS  Google Scholar 

  45. S. Frank B. Stallmeyer H. Kampfer N. Kolbe J. Pfeilschifter (2000) ArticleTitleLeptin enhances wound re-epithelization and constitutes a direct function of leptin in skin repair J. Clin. Invest. 106 501–509 Occurrence Handle10953025 Occurrence Handle1:CAS:528:DC%2BD3cXlvFCltbs%3D Occurrence Handle10.1172/JCI9148

    Article  PubMed  CAS  Google Scholar 

  46. K. Lintner O. Peschard (2000) ArticleTitleBiologically active peptides: from a laboratory bench curiosity to function skin care product Int. J. Cosmet. Sci. 22 207–218 Occurrence Handle1:CAS:528:DC%2BD3cXltFWhs70%3D Occurrence Handle10.1046/j.1467-2494.2000.00010.x Occurrence Handle18503476

    Article  CAS  PubMed  Google Scholar 

  47. C. T. Spann S. C. Taylor J. M. Weinberg (2004) ArticleTitleTopical antimicrobial agents in dermatology Dis. Mon. 50 407–421 Occurrence Handle15280871 Occurrence Handle10.1016/j.disamonth.2004.05.011

    Article  PubMed  Google Scholar 

  48. C. D. Partidos A. S. Beignon F. Mawas G. Belliard J. P. Briand S. Muller (2003) ArticleTitleImmunity under the skin: potential application for topical delivery of vaccines Vaccine 21 776–780 Occurrence Handle12531358 Occurrence Handle1:CAS:528:DC%2BD3sXjtFKmug%3D%3D Occurrence Handle10.1016/S0264-410X(02)00597-2

    Article  PubMed  CAS  Google Scholar 

  49. C. D. Partidos E. Moreau O. Chaloin M. Tunis J. P. Briand C. Desgranges S. Muller (2004) ArticleTitleA synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity Eur. J. Immunol. 34 3723–3731 Occurrence Handle15549730 Occurrence Handle1:CAS:528:DC%2BD2cXhtFajtrjM Occurrence Handle10.1002/eji.200425313

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Alexandre A. Steiner (St. Joseph's Hospital, Phoenix, AZ, USA) for critical comments on the manuscript, Dr. M. Helena. A. Santana (UNICAMP, Campinas, Brazil) for the light scattering analysis, Dr. Katarina Edwards for Cryo-TEM analysis, Dr. Lia Queiroz do Amaral for helpful discussions, Dr. Colleen M. Brophy (ASU, Tempe, USA) for microscopic facilities, and LNLS (project D11A- SAXS-2461) for the SAXRD measurements. This work was supported by “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior” (CAPES, Brazil), Conselho Nacional de Pesquisa (CNPq, Brazil) and “Fundação de Amparo à Pesquisa do Estado de São Paulo” (FAPESP, Brazil). L.B. Lopes was the recipient of a CNPq fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Vitória L. B. Bentley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopes, L.B., Ferreira, D.A., de Paula, D. et al. Reverse Hexagonal Phase Nanodispersion of Monoolein and Oleic Acid for Topical Delivery of Peptides: in Vitro and in Vivo Skin Penetration of Cyclosporin A. Pharm Res 23, 1332–1342 (2006). https://doi.org/10.1007/s11095-006-0143-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-006-0143-7

Key Words

Navigation